Registered Rwanda · Rwanda FDA

LUTENYL

NOMEGESTROL ACETATE

Rwanda FDA-HMP-MA-1519 TABLET 5MG INN generic

What it does

Nomegestrol is a medication used primarily for female reproductive health.

Commonly used for: menstrual disorders, endometriosis, contraception

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
Rwanda FDA-HMP-MA-1519
Registration date
27/07/2024
Expiry date
26/07/2029
Status
Registered
Active ingredient
NOMEGESTROL ACETATE
Dosage form
TABLET
Strength
5MG
Pack size
1x10 Tablets
Therapeutic class
-
Manufacturer / MAH
Laboratoires Macors
Country of origin
France
Manufacturer location
22 Rue des Caillottes, 89000 Auxerre, France

Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:09 · updated 2026-09-21 02:30:20

Disclaimer: This information is sourced from Rwanda Food and Drugs Authority (Rwanda). Always consult a qualified healthcare professional before using any medication.

About this medicine

Nomegestrol is a medication used primarily for female reproductive health.

What it treats

  • menstrual disorders
  • endometriosis
  • contraception

How it works

Nomegestrol works by affecting hormone levels in the body, which helps to regulate menstrual cycles and reduce symptoms related to hormonal imbalances.

Who it's for

This medication is typically for women experiencing hormonal issues or those seeking contraception.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: nomegestrol

BNF-referenced

Nomegestrol is a synthetic progestogen, which is a type of hormone used primarily in various forms of hormonal contraception and in the management of certain gynecological conditions. It mimics the effects of progesterone, a natural hormone involved in the menstrual cycle and pregnancy. Nomegestrol's structure allows it to bind to progesterone receptors, exerting its effects on the reproductive system.

Indications

  • Hormonal contraceptive
  • Management of endometriosis
  • Treatment of abnormal uterine bleeding
  • Management of menopausal symptoms

Dosage

Children: For paediatric use, refer to the BNF for Children for appropriate dosing guidelines.

Adults: The usual dosage for hormonal contraception is one tablet taken orally once daily. For other indications, refer to specific guidelines and clinical recommendations.

Mechanism of action

Nomegestrol acts primarily by binding to progesterone receptors in target tissues, leading to changes in gene expression that affect the menstrual cycle and pregnancy. This action results in the inhibition of ovulation, alteration of the endometrium to prevent implantation, and thickening of cervical mucus, which reduces sperm passage.

Pharmacodynamics

As a progestogen, nomegestrol has effects that include the regulation of the menstrual cycle, prevention of ovulation, and alteration of the endometrium. These effects are crucial in contraceptive methods and in the treatment of conditions like endometriosis and abnormal uterine bleeding.

Pharmacokinetics

Nomegestrol is well absorbed after oral administration. It undergoes hepatic metabolism, primarily by cytochrome P450 enzymes. The elimination half-life is approximately 30-40 hours, allowing for once-daily dosing in contraceptive use. Its metabolites are primarily excreted in urine and feces.

Contra-indications

  • Hypersensitivity to nomegestrol or any of its excipients
  • Severe liver disease
  • Active or previous venous thromboembolism
  • Known or suspected breast cancer or other hormone-sensitive cancers
  • Uncontrolled hypertension
  • Diabetes mellitus with vascular involvement
  • Migraines with aura
  • Pancreatitis
  • Undiagnosed vaginal bleeding

Adverse effects

  • Headache
  • Nausea
  • Breast tenderness
  • Weight gain
  • Mood changes
  • Decreased libido
  • Acne
  • Gastrointestinal disturbances

Interactions

  • Anticonvulsants (e.g., phenytoin, carbamazepine) may reduce efficacy
  • Rifampicin may decrease the effectiveness of nomegestrol
  • St. John's Wort may reduce plasma concentrations
  • Antibiotics may potentially alter the metabolism of nomegestrol, although effect is variable

Precautions

  • Monitor for signs of thromboembolic disorders
  • Consider alternative contraceptive methods in women with a history of thrombosis
  • Use with caution in women with hypertension
  • Regular breast examinations and mammograms should be performed in women using hormonal contraceptives
  • Evaluate risks vs benefits in women with a history of migraines

Pregnancy

Nomegestrol is contraindicated during pregnancy due to potential risks to the fetus.

Breast-feeding

Nomegestrol is excreted in breast milk; caution is advised when used during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Tablets containing nomegestrol 2.5 mg

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: nomegestrol

PubChem CID 68783

Molecular formula: C21H28O3

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.